REQUEST A DEMO
Total
USD $0.00
Search more companies

Cimportpharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Machinery, Equipment, and Supplies Merchant Wholesalers | Health and Personal Care Stores
Full name: Cimportpharma S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Cimportpharma S.A. is an enterprise in Ecuador, with the main office in Samborondon. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Cimportpharma S.A. was incorporated on May 13, 2019. It currently has a total number of 3 (2021) employees. From the latest financial highlights, Cimportpharma S.A. reported a net sales revenue increase of 32.3% in 2022. Its’ total assets recorded a growth of 26.44%. The enterprise’s net profit margin increased by 1.99% in 2022.

Headquarters
Miguel Yunez Zagia S L 14, Centro de Operaciones Almax 2 Bldg. , Floor 203
Samborondon; Guayas;

Contact Details: Purchase the Cimportpharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Cimportpharma S.A. report to view the information.
Outstanding Shares:
Purchase the Cimportpharma S.A. report to view the information.
Registered Capital:
Purchase the Cimportpharma S.A. report to view the information.
Incorporation Date:
May 13, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51.12%
Purchase this report to view the information.
48.88%
Company Performance
Financial values in the chart are available after Cimportpharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
32.3%
Total operating revenue
32.3%
Net Profit (Loss) for the Period
69.35%
Total assets
26.44%
Total equity
38.46%
Net Profit Margin
1.99%
Return on Equity (ROE)
5.06%
Quick Ratio
0.22%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?